Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's a portfolio of dividend shares that could produce £115 of monthly passive income for investors who maximise their ISA ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

Rating upgraded from 66 to 73 Tuesday — a welcome improvement, but still shy of the 80 or better score you prefer to see.

Stock futures rebound as key movers like Calix soar on strong Q1 results, while Medpace, Novo Nordisk, and Zion struggle amid mixed guidance and competition.

We recently published a list of 10 Best Stocks to Buy According to Billionaire Chris Rokos. In this article, we are going to ...

Morgan Stanley downgraded Warner Music Group (NASDAQ: WMG) shares to Equal-weight from Overweight and cut its price target to ...

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management TeamZevra Continues Growth Trajectory into a ...

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

We recently published a list of 10 Value Stocks in Ken Fisher’s Portfolio. In this article, we are going to take a look at where The Goldman Sachs Group, Inc.

CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...